Episode 25: Treatment Revolution in IgA Nephropathy

episode

Previously titled “Episode 25: Treatment Revolution in Iga Nephropathy ” — renamed by the publisher on Aug 3, 2026

KDIGO Conversations in Nephrology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Chris Hipkins: Labour Leader on their policy costings in the wake of PREFU, Adrian Rurawhe's death 10 min · 29 Sep 2026 · The Mike Hosking Breakfast

Nobody Knows What A Coincidence Is 36 min · 29 Sep 2026 · Toni and Ryan

NEW Nancy Guthrie Note?! Teresa Giudice Breaks Her Silence on Milania + Lindsay Clancy INNOCENT?! 52 min · 29 Sep 2026 · No Filter With Zack Peter

NPR News: 09-29-2026 2PM EDT 5 min · 29 Sep 2026 · NPR News Now

2PM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Deebo & Joe - Part 1: Reaction to Bears Beating Eagles + Maurkice Pouncey Joins 1h 4m · 29 Sep 2026 · Club Shay Shay

Report any issue

Source

Recorded02 Oct 2025

Publisheranchor.fm ↗

Handlerec:11055786

Show notes

Join Dana Rizk, MD (University of Alabama at Birmingham, USA), and Shikha Wadhwani, MD (Indiana University School of Medicine, USA), for a conversation on the treatment revolution in IgAN. They discuss how breakthroughs in understanding disease pathophysiology are fueling a wave of new therapies that go beyond traditional supportive care. Key topics include what's changed since the KDIGO 2021 Guideline, the four-hit hypothesis and its role in driving novel therapies, key factors to consider when selecting treatments, and the evolving role of traditional approaches alongside newer agents.This podcast was supported by Travere.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in